03.18.20 -- Uncover The Next Generation Of Immunotherapies

In the last decade, researchers have been studying the biological mechanisms that initiate and control cancer cell growth. This research includes an effort to understand the tumor microenvironment and the influence of checkpoint inhibitors, facilitating the development of personalized therapies focused on treatment of the individual patient and their particular type of cancer.

Hear from experts gathered by Frost and Sullivan about early successes, current challenges, and the future outlook for the development of immunotherapies.

Efficient monitoring of T cell surface markers, cytokines, and expression patterns is critical to the study of immunotherapies. Learn how the ZE5 Cell Analyzer enables you to test these multiple parameters simultaneously.

Learn how Droplet Digital PCR (ddPCR) technology can quickly aid in determining the effectiveness of immune checkpoint inhibitors and other immunotherapies.

See how pairing a cell sorter with a single-cell sequencing solution enables isolation of a rare peripheral blood mononuclear cell population and characterization of heterogeneity within this population.